SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 45 filers reported holding THERAPEUTICSMD INC in Q3 2022. The put-call ratio across all filers is 2.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$47,169
-51.4%
15,619
-33.7%
0.00%
-25.0%
Q2 2023$97,121
-31.9%
23,573
-38.0%
0.00%
+33.3%
Q1 2023$142,658
-32.9%
38,0420.0%0.00%
-25.0%
Q4 2022$212,655
-15.9%
38,0420.0%0.00%0.0%
Q3 2022$253,00038,0420.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,156,953$7,682,0000.39%
SANDERS MORRIS HARRIS LLC 40,393$268,0000.07%
XR Securities LLC 41,200$63,0000.03%
State of Wyoming 8,797$58,0000.03%
J. Goldman & Co LP 82,976$551,0000.03%
Asset Management Group, Inc. 14,701$98,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 12,000$80,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 9,100$60,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 38,042$253,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 15,000$100,0000.00%
View complete list of THERAPEUTICSMD INC shareholders